A potential novel source for biomarker molecules may be protein-rich TF, which has been reported to exhibit altered protein levels in several systemic diseases, including AD (Kalló et al. 2016; Kaštelan et al. 2023; Gijs et al. 2021). Here, TF is linked to Alzheimer disease.